Article Information
History
- December 15, 2020.
Article Versions
- Version 1 (July 11, 2020 - 21:33).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Kévin Jean1,2,3,*,
- Hanaya Raad1,2,4,
- Katy A. M. Gaythorpe3,
- Arran Hamlet3,
- Judith E. Mueller2,4,
- Dan Hogan5,
- Tewodaj Mengistu5,
- Heather J. Whitaker6,7,
- Tini Garske3 and
- Mounia N. Hocine1,2
- 1Laboratoire MESuRS, Conservatoire national des Arts et Métiers, Paris, France
- 2Unité PACRI, Institut Pasteur, Conservatoire National des Arts et Métiers, Paris, France
- 3MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, Imperial College London, United Kingdom
- 4EHESP French School of Public Health, Paris, France
- 5Gavi, the Vaccine Alliance, Geneva, Switzerland
- 6Statistics, Modelling and Economics Department, National Infection Service, Public Health England, Colindale, London, United Kingdom
- 7Department of Mathematics & Statistics, The Open University, Milton Keynes, United Kingdom
- ↵*Corresponding author:
kevin.jean{at}lecnam.net
Posted December 15, 2020.
Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa : a population-level self-controlled case-series study
